Mechanism of Eccentric Cardiomyocyte Hypertrophy Secondary to Severe Mitral Regurgitation

BACKGROUND:Primary valvular heart disease is a prevalent cause of morbidity and mortality in both industrialized and developing countries. Although the primary consequence of valvular heart disease is myocardial dysfunction, treatment of valvular heart diseases centers around valve repair or replace...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Circulation (New York, N.Y.) N.Y.), 2020-06, Vol.141 (22), p.1787-1799
Hauptverfasser: Li, Shujuan, Nguyen, Ngoc Uyen Nhi, Xiao, Feng, Menendez-Montes, Ivan, Nakada, Yuji, Tan, Wilson Lek Wen, Anene-Nzelu, Chukwuemeka George, Foo, Roger S., Thet, Suwannee, Cardoso, Alisson Campos, Wang, Ping, Elhelaly, Waleed M., Lam, Nicholas T., Pereira, Ana Helena Macedo, Hill, Joseph A., Sadek, Hesham A.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1799
container_issue 22
container_start_page 1787
container_title Circulation (New York, N.Y.)
container_volume 141
creator Li, Shujuan
Nguyen, Ngoc Uyen Nhi
Xiao, Feng
Menendez-Montes, Ivan
Nakada, Yuji
Tan, Wilson Lek Wen
Anene-Nzelu, Chukwuemeka George
Foo, Roger S.
Thet, Suwannee
Cardoso, Alisson Campos
Wang, Ping
Elhelaly, Waleed M.
Lam, Nicholas T.
Pereira, Ana Helena Macedo
Hill, Joseph A.
Sadek, Hesham A.
description BACKGROUND:Primary valvular heart disease is a prevalent cause of morbidity and mortality in both industrialized and developing countries. Although the primary consequence of valvular heart disease is myocardial dysfunction, treatment of valvular heart diseases centers around valve repair or replacement rather than prevention or reversal of myocardial dysfunction. This is particularly evident in primary mitral regurgitation (MR), which invariably results in eccentric hypertrophy and left ventricular (LV) failure in the absence of timely valve repair or replacement. The mechanism of LV dysfunction in primary severe MR is entirely unknown. METHODS:Here, we developed the first mouse model of severe MR. Valvular damage was achieved by severing the mitral valve leaflets and chords with iridectomy scissors, and MR was confirmed by echocardiography. Serial echocardiography was performed to follow up LV morphology and systolic function. Analysis of cardiac tissues was subsequently performed to evaluate valve deformation, cardiomyocyte morphology, LV fibrosis, and cell death. Finally, dysregulated pathways were assessed by RNA-sequencing analysis and immunofluorescence. RESULTS:In the ensuing 15 weeks after the induction of MR, gradual LV dilatation and dysfunction occurred, resulting in severe systolic dysfunction. Further analysis revealed that severe MR resulted in a marked increase in cardiac mass and increased cardiomyocyte length but not width, with electron microscopic evidence of sarcomere disarray and the development of sarcomere disruption. From a mechanistic standpoint, severe MR resulted in activation of multiple components of both the mammalian target of rapamycin and calcineurin pathways. Inhibition of mammalian target of rapamycin signaling preserved sarcomeric structure and prevented LV remodeling and systolic dysfunction. Immunohistochemical analysis uncovered a differential pattern of expression of the cell polarity regulator Crb2 (crumbs homolog 2) along the longitudinal axis of cardiomyocytes and close to the intercalated disks in the MR hearts. Electron microscopy images demonstrated a significant increase in polysome localization in close proximity to the intercalated disks and some areas along the longitudinal axis in the MR hearts. CONCLUSIONS:These results indicate that LV dysfunction in response to severe MR is a form of maladaptive eccentric cardiomyocyte hypertrophy and outline the link between cell polarity regulation and spatial locali
doi_str_mv 10.1161/CIRCULATIONAHA.119.043939
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2388819563</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2388819563</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5239-7751d820d55c4bafd32efdc8c9b0d8e28e6795a0f105e5da669524d3064317483</originalsourceid><addsrcrecordid>eNqNUctu2zAQJIoUteP2FwrllotSPkSJPPRgCEltwKmBJD70JNDkylYriQ5JNdDfh4HdArkEuexiBzP7mEXoguArQnLyrVzelZvV_GG5_jlfzCMmr3DGJJMf0JRwmqUZZ_IMTTHGMi0YpRN07v3vWOas4J_QJEIFFVk-Rb9uQe9V3_gusXVyrTX0wTU6KZUzje1Gq8cAyWI8gAvOHvZjcg_a9ka5MQk2Fn_BQXLbBKfa5A52g9s1QYXG9p_Rx1q1Hr6c8gxtbq4fykW6Wv9YlvNVqjllcb2CEyMoNpzrbKtqwyjURgstt9gIoALyQnKFa4I5cKPyXMYLDcN5xkiRCTZDl8e-B2cfB_Ch6hqvoW1VD3bwFWVCCCJ5ziJVHqnaWe8d1NXBNV08pSK4enG2eu1sxGR1dDZqv57GDNsOzH_lPysj4fuR8GTbAM7_aYcncNUeVBv27xqQvaGPv8MMkyKlmMY3xpC-QJI9A981mbY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2388819563</pqid></control><display><type>article</type><title>Mechanism of Eccentric Cardiomyocyte Hypertrophy Secondary to Severe Mitral Regurgitation</title><source>American Heart Association Journals</source><source>Journals@Ovid Complete</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Li, Shujuan ; Nguyen, Ngoc Uyen Nhi ; Xiao, Feng ; Menendez-Montes, Ivan ; Nakada, Yuji ; Tan, Wilson Lek Wen ; Anene-Nzelu, Chukwuemeka George ; Foo, Roger S. ; Thet, Suwannee ; Cardoso, Alisson Campos ; Wang, Ping ; Elhelaly, Waleed M. ; Lam, Nicholas T. ; Pereira, Ana Helena Macedo ; Hill, Joseph A. ; Sadek, Hesham A.</creator><creatorcontrib>Li, Shujuan ; Nguyen, Ngoc Uyen Nhi ; Xiao, Feng ; Menendez-Montes, Ivan ; Nakada, Yuji ; Tan, Wilson Lek Wen ; Anene-Nzelu, Chukwuemeka George ; Foo, Roger S. ; Thet, Suwannee ; Cardoso, Alisson Campos ; Wang, Ping ; Elhelaly, Waleed M. ; Lam, Nicholas T. ; Pereira, Ana Helena Macedo ; Hill, Joseph A. ; Sadek, Hesham A.</creatorcontrib><description>BACKGROUND:Primary valvular heart disease is a prevalent cause of morbidity and mortality in both industrialized and developing countries. Although the primary consequence of valvular heart disease is myocardial dysfunction, treatment of valvular heart diseases centers around valve repair or replacement rather than prevention or reversal of myocardial dysfunction. This is particularly evident in primary mitral regurgitation (MR), which invariably results in eccentric hypertrophy and left ventricular (LV) failure in the absence of timely valve repair or replacement. The mechanism of LV dysfunction in primary severe MR is entirely unknown. METHODS:Here, we developed the first mouse model of severe MR. Valvular damage was achieved by severing the mitral valve leaflets and chords with iridectomy scissors, and MR was confirmed by echocardiography. Serial echocardiography was performed to follow up LV morphology and systolic function. Analysis of cardiac tissues was subsequently performed to evaluate valve deformation, cardiomyocyte morphology, LV fibrosis, and cell death. Finally, dysregulated pathways were assessed by RNA-sequencing analysis and immunofluorescence. RESULTS:In the ensuing 15 weeks after the induction of MR, gradual LV dilatation and dysfunction occurred, resulting in severe systolic dysfunction. Further analysis revealed that severe MR resulted in a marked increase in cardiac mass and increased cardiomyocyte length but not width, with electron microscopic evidence of sarcomere disarray and the development of sarcomere disruption. From a mechanistic standpoint, severe MR resulted in activation of multiple components of both the mammalian target of rapamycin and calcineurin pathways. Inhibition of mammalian target of rapamycin signaling preserved sarcomeric structure and prevented LV remodeling and systolic dysfunction. Immunohistochemical analysis uncovered a differential pattern of expression of the cell polarity regulator Crb2 (crumbs homolog 2) along the longitudinal axis of cardiomyocytes and close to the intercalated disks in the MR hearts. Electron microscopy images demonstrated a significant increase in polysome localization in close proximity to the intercalated disks and some areas along the longitudinal axis in the MR hearts. CONCLUSIONS:These results indicate that LV dysfunction in response to severe MR is a form of maladaptive eccentric cardiomyocyte hypertrophy and outline the link between cell polarity regulation and spatial localization protein synthesis as a pathway for directional cardiomyocyte growth.</description><identifier>ISSN: 0009-7322</identifier><identifier>EISSN: 1524-4539</identifier><identifier>DOI: 10.1161/CIRCULATIONAHA.119.043939</identifier><identifier>PMID: 32272846</identifier><language>eng</language><publisher>United States: by the American College of Cardiology Foundation and the American Heart Association, Inc</publisher><ispartof>Circulation (New York, N.Y.), 2020-06, Vol.141 (22), p.1787-1799</ispartof><rights>by the American College of Cardiology Foundation and the American Heart Association, Inc.</rights><rights>2020 by the American College of Cardiology Foundation and the American Heart Association, Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5239-7751d820d55c4bafd32efdc8c9b0d8e28e6795a0f105e5da669524d3064317483</citedby><cites>FETCH-LOGICAL-c5239-7751d820d55c4bafd32efdc8c9b0d8e28e6795a0f105e5da669524d3064317483</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,3687,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32272846$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Li, Shujuan</creatorcontrib><creatorcontrib>Nguyen, Ngoc Uyen Nhi</creatorcontrib><creatorcontrib>Xiao, Feng</creatorcontrib><creatorcontrib>Menendez-Montes, Ivan</creatorcontrib><creatorcontrib>Nakada, Yuji</creatorcontrib><creatorcontrib>Tan, Wilson Lek Wen</creatorcontrib><creatorcontrib>Anene-Nzelu, Chukwuemeka George</creatorcontrib><creatorcontrib>Foo, Roger S.</creatorcontrib><creatorcontrib>Thet, Suwannee</creatorcontrib><creatorcontrib>Cardoso, Alisson Campos</creatorcontrib><creatorcontrib>Wang, Ping</creatorcontrib><creatorcontrib>Elhelaly, Waleed M.</creatorcontrib><creatorcontrib>Lam, Nicholas T.</creatorcontrib><creatorcontrib>Pereira, Ana Helena Macedo</creatorcontrib><creatorcontrib>Hill, Joseph A.</creatorcontrib><creatorcontrib>Sadek, Hesham A.</creatorcontrib><title>Mechanism of Eccentric Cardiomyocyte Hypertrophy Secondary to Severe Mitral Regurgitation</title><title>Circulation (New York, N.Y.)</title><addtitle>Circulation</addtitle><description>BACKGROUND:Primary valvular heart disease is a prevalent cause of morbidity and mortality in both industrialized and developing countries. Although the primary consequence of valvular heart disease is myocardial dysfunction, treatment of valvular heart diseases centers around valve repair or replacement rather than prevention or reversal of myocardial dysfunction. This is particularly evident in primary mitral regurgitation (MR), which invariably results in eccentric hypertrophy and left ventricular (LV) failure in the absence of timely valve repair or replacement. The mechanism of LV dysfunction in primary severe MR is entirely unknown. METHODS:Here, we developed the first mouse model of severe MR. Valvular damage was achieved by severing the mitral valve leaflets and chords with iridectomy scissors, and MR was confirmed by echocardiography. Serial echocardiography was performed to follow up LV morphology and systolic function. Analysis of cardiac tissues was subsequently performed to evaluate valve deformation, cardiomyocyte morphology, LV fibrosis, and cell death. Finally, dysregulated pathways were assessed by RNA-sequencing analysis and immunofluorescence. RESULTS:In the ensuing 15 weeks after the induction of MR, gradual LV dilatation and dysfunction occurred, resulting in severe systolic dysfunction. Further analysis revealed that severe MR resulted in a marked increase in cardiac mass and increased cardiomyocyte length but not width, with electron microscopic evidence of sarcomere disarray and the development of sarcomere disruption. From a mechanistic standpoint, severe MR resulted in activation of multiple components of both the mammalian target of rapamycin and calcineurin pathways. Inhibition of mammalian target of rapamycin signaling preserved sarcomeric structure and prevented LV remodeling and systolic dysfunction. Immunohistochemical analysis uncovered a differential pattern of expression of the cell polarity regulator Crb2 (crumbs homolog 2) along the longitudinal axis of cardiomyocytes and close to the intercalated disks in the MR hearts. Electron microscopy images demonstrated a significant increase in polysome localization in close proximity to the intercalated disks and some areas along the longitudinal axis in the MR hearts. CONCLUSIONS:These results indicate that LV dysfunction in response to severe MR is a form of maladaptive eccentric cardiomyocyte hypertrophy and outline the link between cell polarity regulation and spatial localization protein synthesis as a pathway for directional cardiomyocyte growth.</description><issn>0009-7322</issn><issn>1524-4539</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNqNUctu2zAQJIoUteP2FwrllotSPkSJPPRgCEltwKmBJD70JNDkylYriQ5JNdDfh4HdArkEuexiBzP7mEXoguArQnLyrVzelZvV_GG5_jlfzCMmr3DGJJMf0JRwmqUZZ_IMTTHGMi0YpRN07v3vWOas4J_QJEIFFVk-Rb9uQe9V3_gusXVyrTX0wTU6KZUzje1Gq8cAyWI8gAvOHvZjcg_a9ka5MQk2Fn_BQXLbBKfa5A52g9s1QYXG9p_Rx1q1Hr6c8gxtbq4fykW6Wv9YlvNVqjllcb2CEyMoNpzrbKtqwyjURgstt9gIoALyQnKFa4I5cKPyXMYLDcN5xkiRCTZDl8e-B2cfB_Ch6hqvoW1VD3bwFWVCCCJ5ziJVHqnaWe8d1NXBNV08pSK4enG2eu1sxGR1dDZqv57GDNsOzH_lPysj4fuR8GTbAM7_aYcncNUeVBv27xqQvaGPv8MMkyKlmMY3xpC-QJI9A981mbY</recordid><startdate>20200602</startdate><enddate>20200602</enddate><creator>Li, Shujuan</creator><creator>Nguyen, Ngoc Uyen Nhi</creator><creator>Xiao, Feng</creator><creator>Menendez-Montes, Ivan</creator><creator>Nakada, Yuji</creator><creator>Tan, Wilson Lek Wen</creator><creator>Anene-Nzelu, Chukwuemeka George</creator><creator>Foo, Roger S.</creator><creator>Thet, Suwannee</creator><creator>Cardoso, Alisson Campos</creator><creator>Wang, Ping</creator><creator>Elhelaly, Waleed M.</creator><creator>Lam, Nicholas T.</creator><creator>Pereira, Ana Helena Macedo</creator><creator>Hill, Joseph A.</creator><creator>Sadek, Hesham A.</creator><general>by the American College of Cardiology Foundation and the American Heart Association, Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20200602</creationdate><title>Mechanism of Eccentric Cardiomyocyte Hypertrophy Secondary to Severe Mitral Regurgitation</title><author>Li, Shujuan ; Nguyen, Ngoc Uyen Nhi ; Xiao, Feng ; Menendez-Montes, Ivan ; Nakada, Yuji ; Tan, Wilson Lek Wen ; Anene-Nzelu, Chukwuemeka George ; Foo, Roger S. ; Thet, Suwannee ; Cardoso, Alisson Campos ; Wang, Ping ; Elhelaly, Waleed M. ; Lam, Nicholas T. ; Pereira, Ana Helena Macedo ; Hill, Joseph A. ; Sadek, Hesham A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5239-7751d820d55c4bafd32efdc8c9b0d8e28e6795a0f105e5da669524d3064317483</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Li, Shujuan</creatorcontrib><creatorcontrib>Nguyen, Ngoc Uyen Nhi</creatorcontrib><creatorcontrib>Xiao, Feng</creatorcontrib><creatorcontrib>Menendez-Montes, Ivan</creatorcontrib><creatorcontrib>Nakada, Yuji</creatorcontrib><creatorcontrib>Tan, Wilson Lek Wen</creatorcontrib><creatorcontrib>Anene-Nzelu, Chukwuemeka George</creatorcontrib><creatorcontrib>Foo, Roger S.</creatorcontrib><creatorcontrib>Thet, Suwannee</creatorcontrib><creatorcontrib>Cardoso, Alisson Campos</creatorcontrib><creatorcontrib>Wang, Ping</creatorcontrib><creatorcontrib>Elhelaly, Waleed M.</creatorcontrib><creatorcontrib>Lam, Nicholas T.</creatorcontrib><creatorcontrib>Pereira, Ana Helena Macedo</creatorcontrib><creatorcontrib>Hill, Joseph A.</creatorcontrib><creatorcontrib>Sadek, Hesham A.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Circulation (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Li, Shujuan</au><au>Nguyen, Ngoc Uyen Nhi</au><au>Xiao, Feng</au><au>Menendez-Montes, Ivan</au><au>Nakada, Yuji</au><au>Tan, Wilson Lek Wen</au><au>Anene-Nzelu, Chukwuemeka George</au><au>Foo, Roger S.</au><au>Thet, Suwannee</au><au>Cardoso, Alisson Campos</au><au>Wang, Ping</au><au>Elhelaly, Waleed M.</au><au>Lam, Nicholas T.</au><au>Pereira, Ana Helena Macedo</au><au>Hill, Joseph A.</au><au>Sadek, Hesham A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Mechanism of Eccentric Cardiomyocyte Hypertrophy Secondary to Severe Mitral Regurgitation</atitle><jtitle>Circulation (New York, N.Y.)</jtitle><addtitle>Circulation</addtitle><date>2020-06-02</date><risdate>2020</risdate><volume>141</volume><issue>22</issue><spage>1787</spage><epage>1799</epage><pages>1787-1799</pages><issn>0009-7322</issn><eissn>1524-4539</eissn><abstract>BACKGROUND:Primary valvular heart disease is a prevalent cause of morbidity and mortality in both industrialized and developing countries. Although the primary consequence of valvular heart disease is myocardial dysfunction, treatment of valvular heart diseases centers around valve repair or replacement rather than prevention or reversal of myocardial dysfunction. This is particularly evident in primary mitral regurgitation (MR), which invariably results in eccentric hypertrophy and left ventricular (LV) failure in the absence of timely valve repair or replacement. The mechanism of LV dysfunction in primary severe MR is entirely unknown. METHODS:Here, we developed the first mouse model of severe MR. Valvular damage was achieved by severing the mitral valve leaflets and chords with iridectomy scissors, and MR was confirmed by echocardiography. Serial echocardiography was performed to follow up LV morphology and systolic function. Analysis of cardiac tissues was subsequently performed to evaluate valve deformation, cardiomyocyte morphology, LV fibrosis, and cell death. Finally, dysregulated pathways were assessed by RNA-sequencing analysis and immunofluorescence. RESULTS:In the ensuing 15 weeks after the induction of MR, gradual LV dilatation and dysfunction occurred, resulting in severe systolic dysfunction. Further analysis revealed that severe MR resulted in a marked increase in cardiac mass and increased cardiomyocyte length but not width, with electron microscopic evidence of sarcomere disarray and the development of sarcomere disruption. From a mechanistic standpoint, severe MR resulted in activation of multiple components of both the mammalian target of rapamycin and calcineurin pathways. Inhibition of mammalian target of rapamycin signaling preserved sarcomeric structure and prevented LV remodeling and systolic dysfunction. Immunohistochemical analysis uncovered a differential pattern of expression of the cell polarity regulator Crb2 (crumbs homolog 2) along the longitudinal axis of cardiomyocytes and close to the intercalated disks in the MR hearts. Electron microscopy images demonstrated a significant increase in polysome localization in close proximity to the intercalated disks and some areas along the longitudinal axis in the MR hearts. CONCLUSIONS:These results indicate that LV dysfunction in response to severe MR is a form of maladaptive eccentric cardiomyocyte hypertrophy and outline the link between cell polarity regulation and spatial localization protein synthesis as a pathway for directional cardiomyocyte growth.</abstract><cop>United States</cop><pub>by the American College of Cardiology Foundation and the American Heart Association, Inc</pub><pmid>32272846</pmid><doi>10.1161/CIRCULATIONAHA.119.043939</doi><tpages>13</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0009-7322
ispartof Circulation (New York, N.Y.), 2020-06, Vol.141 (22), p.1787-1799
issn 0009-7322
1524-4539
language eng
recordid cdi_proquest_miscellaneous_2388819563
source American Heart Association Journals; Journals@Ovid Complete; EZB-FREE-00999 freely available EZB journals
title Mechanism of Eccentric Cardiomyocyte Hypertrophy Secondary to Severe Mitral Regurgitation
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T09%3A24%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Mechanism%20of%20Eccentric%20Cardiomyocyte%20Hypertrophy%20Secondary%20to%20Severe%20Mitral%20Regurgitation&rft.jtitle=Circulation%20(New%20York,%20N.Y.)&rft.au=Li,%20Shujuan&rft.date=2020-06-02&rft.volume=141&rft.issue=22&rft.spage=1787&rft.epage=1799&rft.pages=1787-1799&rft.issn=0009-7322&rft.eissn=1524-4539&rft_id=info:doi/10.1161/CIRCULATIONAHA.119.043939&rft_dat=%3Cproquest_cross%3E2388819563%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2388819563&rft_id=info:pmid/32272846&rfr_iscdi=true